• OPEN AN ACCOUNT
Indian Indices
Sensex
74,729.27 413.66
( 0.56%)
Global Indices
Nasdaq
52,025.19 -173.50
(-0.33%)
Dow Jones
7,682.22 -82.84
(-1.07%)
Hang Seng
65,489.63 1,063.68
(1.65%)
Nikkei 225
10,879.96 39.61
(0.37%)
Forex
USD-INR
94.85 -0.23
(-0.24%)
EUR-INR
106.35 0.11
(0.11%)
GBP-INR
125.73 -0.01
(-0.01%)
JPY-INR
0.60 0.00
(0.07%)

EQUITY - MARKET SCREENER

Pratham EPC Projects Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
92293
INE0QA601016
47.1735022
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
PRATHAM
216
196.69
EPS(TTM)
Face Value()
Div & Yield %
0.5
10
0
 

pakka ltd
InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.